Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skibber, J. M.
Right arrow Articles by Sawaya, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skibber, J. M.
Right arrow Articles by Sawaya, R. E.

Annals of Surgical Oncology, Vol 3, Issue 2 118-123, Copyright © 1996 by Society of Surgical Oncology

ARTICLES

Cranial irradiation after surgical excision of brain metastases in melanoma patients

J. M. Skibber, S. J. Soong, L. Austin, C. M. Balch and R. E. Sawaya
Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

BACKGROUND: Brain metastases account for 20-54% of reported deaths from melanoma. Duration and quality of survival depend on the extent of metastatic disease and response to treatment. Treatment goals are palliation of symptoms and prolongation of life. No studies have directly compared surgery alone and surgery with adjunctive cranial irradiation in patients with solitary brain metastases. METHODS: We evaluated postoperative adjunctive cranial irradiation in 34 patients with solitary brain metastases. RESULTS: Overall survival was significantly improved in the 22 patients who received adjunctive cranial irradiation versus that in the 12 patients who had surgery alone. Twenty-eight patients subsequently relapsed. Nine of 10 patients with surgery alone had brain recurrence as a component of failure. Six of 10 patients not receiving irradiation had brain recurrences as a component of relapse at multiple sites whereas only 1 of 18 patients receiving irradiation relapsed with the brain. CONCLUSIONS: Adjunctive cranial irradiation is justified for melanoma patients who undergo surgical therapy for solitary brain metastases. Survival in patients presenting with solitary brain metastases was improved by a reduction of relapse in the brain as a component of failure by combined surgery and irradiation.


This article has been cited by other articles:


Home page
 JCOHome page
K.M. Fife, M.H. Colman, G.N. Stevens, I.C. Firth, D. Moon, K.F. Shannon, R. Harman, K. Petersen-Schaefer, A.C. Zacest, M. Besser, et al.
Determinants of Outcome in Melanoma Patients With Cerebral Metastases
J. Clin. Oncol., April 1, 2004; 22(7): 1293 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
E. L. Chang and S. Lo
Diagnosis and Management of Central Nervous System Metastases from Breast Cancer
Oncologist, October 1, 2003; 8(5): 398 - 410.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. C. Hsueh, R. Essner, L. J. Foshag, D. W. Ollila, G. Gammon, S. J. O'Day, P. D. Boasberg, S. L. Stern, X. Ye, and D. L. Morton
Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine
J. Clin. Oncol., December 1, 2002; 20(23): 4549 - 4554.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. A. Patchell, P. A. Tibbs, W. F. Regine, R. J. Dempsey, M. Mohiuddin, R. J. Kryscio, W. R. Markesbery, K. A. Foon, and B. Young
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
JAMA, November 4, 1998; 280(17): 1485 - 1489.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society of Surgical Oncology.